'60ml min' diaporamas de présentation

Anaemia management in people with chronic kidney disease

Anaemia management in people with chronic kidney disease. September, 2006. changing clinical practice . NICE guidelines are based on the best available evidence the Department of Health asks NHS organisations to work towards implementing guidelines

736 views • 24 slides

Preferred treatment options for patients with Diabetes

439 views • 23 slides

Chronic Kidney Disease

Chronic Kidney Disease. What is CKD?. Definition: GFR < 60mL/min/1.73m 2 for > 3 months +/- evidence of kidney damage OR Evidence of kidney damage for > 3 months +/- decreased GFR Microalbuminaemia Proteinuria Glomerular haematuria Pathological abnormalities Anatomical abnormalities.

340 views • 14 slides

171 views • 5 slides

Lenalidomide |LENALID 5MG,10MG,15MG,25MG|Blueberry pharmaceuticals

The most common indications ofu00a0Lenalidu00a05mg,10mg,15mg,25mgu00a0are; Multiple myeloma: Lenalid 5mg should be used in combination with dexamethasone.u00a0 Myelodysplastic syndrome:u00a0Lenalidu00a05mg,10mg,15mg,25mgu00a0u00a0is used to treat this condition Mantle cell lymphoma:u00a0Lenalidu00a05mg,10mg,15mg,25mgu00a0is used for this condition, if patients are not responding to the Bortezomib treatment.

48 views • 4 slides